Is My Child Too Short? What the Growth Curve Actually Tells You
Every class photo has a shortest kid. If it's yours, you've probably done the math in your head: he was the smallest last year too. His cousin is already taller. Shouldn't he have caught up by now?
Here is the first thing worth knowing. A single height measurement tells a clinician very little. What matters is the line your child draws over time.
Speed matters more than size
Children grow at a fairly predictable pace:
Ages 2 to 3: about 8 cm (3 in) a year.
Ages 3 to 5: about 7 cm (2¾ in) a year.
Age 5 until puberty: 5 to 6 cm (2 to 2½ in) a year.
During the pubertal growth spurt: 8 to 12 cm (3 to 4¾ in) a year for girls, 10 to 14 cm (4 to 5½ in) for boys.
A child who is small but grows 5 to 6 cm every year is following his own track. A child of average height who has grown only 3 cm this year deserves more attention than the small one. That is why two measurements, ideally 6 to 12 months apart, are worth more than any comparison with classmates.
What a percentile really means
The 10th percentile is not a grade. It means that out of 100 healthy children of the same age and sex, 10 are shorter and 90 are taller. Someone has to be at the 10th percentile, and most of those children are perfectly healthy.
Doctors use the term short stature when height falls below the 3rd percentile (more than two standard deviations below the average). Even then, the most common explanations are not diseases.
One more detail for families who moved here. In the U.S., pediatricians use WHO charts for children under 2 and CDC charts from 2 to 20. Charts used in other countries are built on different populations, so the percentile you were told back home may not match. If you have old measurements from your previous pediatrician, bring them. Those numbers are valuable: they show the trajectory.
What the parents' heights predict
Genetics sets the range. The mid-parental height formula gives a rough target:
For a boy: (father's height + mother's height + 13 cm) ÷ 2
For a girl: (father's height + mother's height − 13 cm) ÷ 2
In inches, use 5 in place of 13 cm. Most children end up within about 10 cm (4 in) of that number, in either direction. If mom is 158 cm (5'2") and dad is 170 cm (5'7"), a son's target is around 170.5 cm (5'7"), with a normal range from roughly 160 to 180 cm. A child tracking along the 10th percentile in that family is doing exactly what his genes predict.
The two most common reasons, and neither is a disease
Familial short stature. Short parents, a short child, steady growth along a low percentile, puberty at the usual time. Bone age matches the child's actual age.
Constitutional delay, or "late bloomers." These children grow normally in early childhood, then drift lower on the chart, enter puberty later than their friends, and keep growing after everyone else has stopped. There is often a parent who "shot up in tenth grade" or a mother whose periods started late. Their bone age is younger than their actual age, which means there is more growing time left.
Bone age is a simple X-ray of the left hand and wrist. It shows how mature the growth plates are, and it is one of the most useful tests in this whole evaluation.
Signs that deserve an evaluation
Growing less than 5 cm (2 in) a year between age 5 and the start of puberty.
Crossing downward through two major percentile lines on the chart.
Height far below what the parents' heights predict (more than about 10 cm under the mid-parental target).
Height well below the 3rd percentile.
No signs of puberty by 13 in girls or 14 in boys.
Poor growth together with other symptoms: long-lasting diarrhea or belly pain, fatigue, headaches, poor appetite, weight loss, or a child who is short and gaining weight quickly.
An evaluation usually starts simply: accurate measurements, the growth history, parents' heights, a physical exam, a bone age X-ray, and basic blood tests. These commonly include a complete blood count (CBC), a metabolic panel, thyroid tests (TSH, free T4), celiac screening (tTG-IgA) and IGF-1. Celiac disease and an underactive thyroid can show up as slow growth with few other symptoms, and both are treatable.
What you can actually influence
Enough food, and enough protein in it. Children who are chronically under-eating, including very picky eaters and teens restricting food, grow more slowly.
Sleep. Growth hormone is released mostly during deep sleep. The evidence that ordinary short nights make a healthy child shorter is weak, but chronic sleep deprivation is worth fixing for many reasons.
Good control of chronic conditions. Poorly controlled asthma, inflammatory bowel disease, kidney disease and long-term oral steroids all affect growth.
Regular well-child visits, so there are real measurements to look at.
What does not work
Hanging from a bar, stretching and "growth exercises" do not lengthen bones.
Basketball and swimming do not make children taller. Tall children tend to stay in those sports.
Lifting weights does not stunt growth. The American Academy of Pediatrics supports properly supervised strength training for children and teens.
"Height growth" supplements have no good evidence behind them. Supplements are not reviewed by the FDA for effectiveness before they are sold. Vitamins and minerals help a child grow only when that child is actually deficient.
About growth hormone, and the weekly shot in the news
Growth hormone is a prescription treatment with specific FDA-approved uses: growth hormone deficiency, Turner syndrome, Noonan syndrome, Prader-Willi syndrome, chronic kidney disease, children born small for gestational age who did not catch up, and idiopathic short stature, meaning significant short stature with no identified cause.
In February 2026 the FDA extended a once-weekly growth hormone, somapacitan (Sogroya), to three more groups of children aged 2.5 and older: idiopathic short stature, children born small for gestational age without catch-up growth, and Noonan syndrome. In the trial behind the approval, the weekly injection produced growth over one year that was comparable to daily injections. For families already on daily shots, that is a real convenience.
It is not a shortcut to a taller child. In otherwise healthy short children, a systematic review found that years of treatment added about 4 cm (1½ in) to adult height on average, with a wide range between children. Treatment means injections for years, regular monitoring and a very high cost. The Pediatric Endocrine Society advises against routine use in idiopathic short stature and recommends deciding case by case, with a pediatric endocrinologist, after weighing the burden against a modest and uncertain benefit.
Where to start
Collect your child's past measurements and add one new, accurate one: no shoes, heels against the wall, looking straight ahead. Then put the numbers into the free growth calculator on the Patient Tools page at dobromedonline.com. It shows height, weight and BMI percentiles, growth velocity and the mid-parental target height.
If the curve is steady, you can relax. If it is flattening, or you see any of the signs above, bring the printout to your child's pediatrician. That conversation goes much better with a chart in hand.
This article is educational and does not replace an evaluation by a clinician.
Sources
Barstow C, Rerucha C. Evaluation of Short and Tall Stature in Children. Am Fam Physician. 2015. https://www.aafp.org/afp/2015/0701/p43
Mameli C, et al. Clinical and biochemical evaluation of children with short stature in the primary care setting: a systematic review. Ital J Pediatr. 2026. https://doi.org/10.1186/s13052-026-02215-8
Grimberg A, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents. Pediatric Endocrine Society. Horm Res Paediatr. 2016. PMID 27884013
Deodati A, Cianfarani S. Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review. BMJ. 2011. PMID 21398350
FDA approves three new pediatric indications for once-weekly growth hormone injection (somapacitan-beco, Sogroya). Healio, February 27, 2026. https://www.healio.com/news/endocrinology/20260227/fda-approves-three-new-pediatric-indications-for-onceweekly-growth-hormone-injection
CDC. Growth Charts: WHO charts for ages 0-2, CDC charts for ages 2-20. https://www.cdc.gov/growthcharts/
American Academy of Pediatrics. Resistance Training for Children and Adolescents. Pediatrics. 2020. https://doi.org/10.1542/peds.2020-1011
Comments